PI
IBB icon

Parkside Investments’s iShares Biotechnology ETF IBB Stock Holding History

Parkside Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,500
Closed -$480K – 93
2024
Q1 		$480K Hold
3,500
– – 0.08% 78
2023
Q4 		$475K Hold
3,500
– – 0.08% 84
2023
Q3 		$428K Hold
3,500
– – 0.08% 74
2023
Q2 		$444K Hold
3,500
– – 0.08% 73
2023
Q1 		$452K Hold
3,500
– – 0.09% 80
2022
Q4 		$460K Buy
+3,500
New +$452K 0.09% 81
2022
Q1 		– Sell
-1,500
Closed -$228K – 160
2021
Q4 		$228K Hold
1,500
– – 0.04% 84
2021
Q3 		$242K Sell
1,500
-550
-27% -$92.6K 0.05% 84
2021
Q2 		$335K Buy
+2,050
New +$316K 0.06% 81
2019
Q4 		– Sell
-27,399
Closed -$2.73M – 116
2019
Q3 		$2.73M Sell
27,399
-23,190
-46% -$2.43M 0.73% 57
2019
Q2 		$5.52M Sell
50,589
-11,380
-18% -$1.21M 1.44% 21
2019
Q1 		$6.93M Buy
61,969
+21,737
+54% +$2.38M 1.89% 12
2018
Q4 		$3.88M Buy
40,232
+4,890
+14% +$519K 1.68% 13
2018
Q3 		$4.31M Buy
35,342
+475
+1% +$55.9K 2.04% 8
2018
Q2 		$3.97M Sell
34,867
-9,345
-21% -$999K 1.94% 8
2018
Q1 		$4.72M Sell
44,212
-7,275
-14% -$806K 2.46% 7
2017
Q4 		$5.5M Buy
51,487
+2,641
+5% +$282K 2.68% 4
2017
Q3 		$5.43M Buy
48,846
+651
+1% +$69.6K 3.13% 4
2017
Q2 		$4.98M Buy
48,195
+405
+0.8% +$39.9K 3.1% 4
2017
Q1 		$4.67M Buy
+47,790
New +$4.58M 3.3% 2

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Parkside Investments's IBB Position: Q2 2024 in Review

Parkside Investments sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 3,500 shares — an estimated $480K sold.

Parkside Investments first reported a position in IBB in Q1 2017 and held it in 20 quarters. The position peaked at $6.93M in Q1 2019. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

  • Parkside Investments reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
  • Parkside Investments sold 3,500 iShares Biotechnology ETF shares in Q2 2024, an estimated $480K.
  • Parkside Investments first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 20 quarters.
  • Parkside Investments's iShares Biotechnology ETF position peaked at $6.93M in Q1 2019.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Parkside Investments's 13F filing for Q2 2024, filed 11 Jul 2024.